Evidence map›Paper›PMID 34132118›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

The common ABCA3

Yaniv Tomer, Jennifer Wambach, Lars Knudsen, Ming Zhao, Luis R Rodriguez, Aditi Murthy, Frances V White, Alessandro Venosa, Jeremy Katzen, Matthias Ochs and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Lentiviral-mediated gene complementation to rescue pathogenic ABCA3 variants.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Article
  3. Review
  4. Biallelic LAMP3 variants in 5 families with interstitial lung disease: Evidence of a disease-gene association.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  5. Article
  6. Lentiviral-mediated gene complementation rescues pathogenicbioRxiv : the preprint server for biology · 2025
    Article
  7. Respirology case reports · 2025
    Article
  8. Review
  9. THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.Transactions of the American Clinical and Climatological Association · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases.American journal of respiratory cell and molecular biology · 2022
    Review
  20. First Steps toward Personalized Therapies for ABCA3 Deficiency.American journal of respiratory cell and molecular biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Yaniv TomerDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Jennifer WambachDivision of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Lars KnudsenInstitute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.
Ming ZhaoDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Luis R RodriguezDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Aditi MurthyDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Frances V WhiteDeparment of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri.
Alessandro VenosaDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-3741-2634
Jeremy KatzenDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Matthias OchsInstitute of Functional Anatomy, Charité - Universitaetsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-0936-6979
Aaron HamvasDivision of Neonatology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Michael F BeersDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-2149-3209
Surafel MulugetaDivision of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-8734-8688
University of Pennsylvania · USChildren's Hospital of Philadelphia · USWashington University in St. Louis · USGerman Center for Lung Research · DEMedizinische Hochschule Hannover · DENorthwestern University · USUniversity of Utah · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
TRAINING IN PULMONARY IMMUNOLOGYT32HL007586 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MEYER, NUALA JENNINGS · 1985 to 2025
$8.8M
Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular TargetsR01HL145408 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MICHAEL FRANCIS BEERS · 2019 to 2026
$4.6M
Functional Characterization of ABCA3 Genomic VariantsR01HL149853 · NHLBI · WASHINGTON UNIVERSITY · PI Jennifer Wambach · 2020 to 2026
$3.9M
The Biology of the ABCA3 Lipid Transporter in Health and DiseaseR01HL129150 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MULUGETA, SURAFEL · 2016 to 2019
$1.9M
Understanding how alveolar epithelial cell stress drives aberrant repair in interstitial lung diseaseK08HL150226 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KATZEN, JEREMY BINDER · 2020 to 2024
$840k
Surfactant Protein C Mutations and Interstitial Lung DiseaseI01BX001176 · VA · PHILADELPHIA VA MEDICAL CENTER · PI MICHAEL FRANCIS BEERS · 2012 to 2026
–
BLRD VA I01 BX001176HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL145408HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL150226HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) P30ES013508NHLBI NIH HHS K08 HL150226NHLBI NIH HHS R01 HL129150NHLBI NIH HHS R01 HL145408NHLBI NIH HHS R01 HL149853NHLBI NIH HHS T32 HL007586NIEHS NIH HHS P30 ES013508
6 · The paper itself

Abstract

ATP-binding cassette class A3 (ABCA3) is a lipid transporter that plays a critical role in pulmonary surfactant function. The substitution of valine for glutamic acid at codon 292 (E292V) produces a hypomorphic variant that accounts for a significant portion of

Indexed as

Alveolar Epithelial CellsATP-Binding Cassette TransportersAutophagyGene Expression RegulationLung InjuryMutation, MissenseAmino Acid SubstitutionAnimalsMiceMice, Mutant StrainsPulmonary FibrosisRespiratory Distress Syndrome, NewbornAbca3 protein, mouseATP-Binding Cassette TransportersABCA3autophagydiffuse parenchymal lung diseaselung epitheliumpulmonary fibrosis

Identifiers

PMID34132118
PMCPMC8410113
OpenAlexW3170935746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.